Cannabix Technologies Inc.

Equities

BLO

CA13765L1013

Advanced Medical Equipment & Technology

Market Closed - Canadian Securities Exchange Other stock markets 03:59:51 2024-05-01 pm EDT			5-day change	1st Jan Change
0.45 ^CAD	0.00%		+13.92%	+150.00%

Apr. 25	Cannabix Up 28% as it Says Breath Logix Alcohol Device Delivers "Positive Impact" to Private Monitoring Agency in Montana	MT
Apr. 16	Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands Product Series to Breath Logix	CI

Cannabix Technologies Inc. Announces Resignation of Kulwant Malhi as President and Director

March 29, 2024 at 12:55 am EDT

Cannabix Technologies Inc. announced that Kulwant Malhi has resigned as President and Director. Mr. Malhi is the CEO of privately held BullRun Capital Inc. and founded Cannabix Technologies Inc. in 2014 and was integral in Cannabix Technologies Inc. becoming a public company on the Canadian Securities Exchange and subsequent financing rounds.

Latest news about Cannabix Technologies Inc.

Cannabix Up 28% as it Says Breath Logix Alcohol Device Delivers "Positive Impact" to Private Monitoring Agency in Montana	Apr. 25	MT
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands Product Series to Breath Logix	Apr. 16	CI
Cannabix Technologies Inc. Appoints Phillip Olla to its Board of Directors	Apr. 02	CI
Cannabix Technologies Inc. Announces Resignation of Kulwant Malhi as President and Director	Mar. 29	CI
Cannabix Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	Mar. 18	CI
Cannabix Up Over 8% After Reporting Patent for Proprietary Laboratory Drug Analysis Device	Jan. 03	MT
Cannabix Technologies Inc. Files Patent for Proprietary Laboratory Drug Analysis Device	Jan. 03	CI
Cannabix Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	Dec. 15	CI
Cannabix Technologies Inc. Completes Initial Electronics Testing on Contactless Alcohol Breathalyzer, Commences International Certification Plans	Nov. 07	CI
Cannabix Technologies Inc. Reports its Mass Spectrometer Breath Sampler Technology Along with Breath Collection Unit Uses to Quantify Delta-9 THC Levels from Smoking and Edibles in Humans	23-10-03	CI
Cannabix Technologies Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023	23-09-26	CI
Cannabix Technologies Inc. Reports Earnings Results for the Full Year Ended April 30, 2023	23-08-24	CI
Cannabix Technologies Inc. Files Breath Sample Capture Patent and Detects Delta- 8 THC in Early Testing	23-08-04	CI
Cannabix Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	23-03-29	CI
Cannabix Technologies' Breathalyzer Slated for Test Program at Montana Company	23-02-13	MT
Cannabix Technologies Inc. to Test Contactless Alcohol Breathalyzer in Montana	23-02-13	CI
Cannabix Technologies Inc. Enters into Memorandum of Understanding with the North Louisiana Criminalistics Laboratory	23-01-05	CI
Cannabix Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	22-12-21	CI
Warren County, PA Police to Pilot Cannabix Marijuana Breathalyzer Technology	22-11-07	CI
Cannabix Technologies Inc Creates Contactless Alcohol Breath Detection Technology for Workplace and Vehicles	22-10-17	CI
Cannabix Technologies Inc. Announces Participating in A Mid-October Study Date to Test A Supplemental Version of Its Faims Technology for Detection of 9-Tetrahydrocannabino	22-10-11	CI
Cannabix Technologies Inc. Reports Earnings Results for the First Quarter Ended July 31, 2022	22-09-21	CI
Cannabix Technologies Inc. Announces Development of Marijuana Breathalyzer Devices to Give Law Enforcement and Employers A Tool to Enhance Public Safety	22-08-25	CI
Cannabix Technologies Inc. Correlates THC in Breath and Blood Using Proprietary Sample Collection and Analysis Hardware in Southern US Study	22-08-25	CI
Cannabix Technologies Inc. Reports Earnings Results for the Full Year Ended April 30, 2022	22-08-17	CI

Chart Cannabix Technologies Inc.

Duration

Period

More charts

Company Profile

Cannabix Technologies Inc. is a Canada-based developer of marijuana and alcohol breath testing devices. The Companyâs primary business is the development of marijuana breathalyzer technology. It is developing technologies to detect Tetrahydrocannabinol (THC) in breath samples for law enforcement, employers and laboratories. In addition, it is developing non-contact alcohol screening devices targeted primarily for workplace settings. The MS Breath Sampler (MSBS) is specialized laboratory hardware developed by the Company to confirm THC in breath from humans. The MSBS is a method for collection of analytes of low volatility from human breath utilizing liquid secondary adsorption. Within the Breath Collection Unit (THC detection), the sample is captured inside a cartridge and loaded into the MSBS. In preliminary testing, the system has detected and confirmed THC in breath out to four hours after smoking with breath samples being stored and analyzed up to two days after sample collection.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-06-17 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
CANNABIX TECHNOLOGIES INC.	+150.00%	34.05M
THERMO FISHER SCIENTIFIC	+8.33%	217B
DANAHER CORPORATION	+6.72%	183B
INTUITIVE SURGICAL, INC.	+10.18%	131B
BOSTON SCIENTIFIC CORPORATION	+24.91%	106B
SIEMENS HEALTHINEERS AG	-0.95%	62.16B
EDWARDS LIFESCIENCES CORPORATION	+10.56%	51.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.81%	50.89B
AGILENT TECHNOLOGIES, INC.	-0.24%	40.16B
GE HEALTHCARE TECHNOLOGIES INC.	+1.22%	34.79B

Other Advanced Medical Equipment & Technology